Nidufexor, a non-bile acid FXR agonist, decreases ALT and...

Journal of Hepatology 2020 / 08 Vol. 73

Nidufexor, a non-bile acid FXR agonist, decreases ALT and hepatic fat fraction in patients with NASH after 12 weeks dosing

Aspinall, Richard, Shennak, Mustafa, Stocia, George, Quinn, Dean, Javashvili, Lali, Molteni, Valentina, Ukomadu, Chinweike, Sohal, Bindi, Zhang, Yiming, Martic, Miljen, Avrameas, Alexandre, Kao, Sheen
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
73
Journal:
Journal of Hepatology
DOI:
10.1016/S0168-8278(20)30570-5
Date:
August, 2020
File:
PDF, 56 KB
2020
Conversion to is in progress
Conversion to is failed